Steffen Pietzke
2017 - PDL BioPharma
In 2017, Steffen Pietzke earned a total compensation of $793.9K as Vice President, Finance and Chief Accounting Officer at PDL BioPharma, a 26% increase compared to previous year.
Compensation breakdown
| Bonus | $125,000 |
|---|---|
| Non-Equity Incentive Plan | $112,892 |
| Salary | $316,004 |
| Stock Awards | $200,000 |
| Other | $40,000 |
| Total | $793,896 |
Pietzke received $316K in salary, accounting for 40% of the total pay in 2017.
Pietzke also received $125K in bonus, $112.9K in non-equity incentive plan, $200K in stock awards and $40K in other compensation.
Rankings
In 2017, Steffen Pietzke's compensation ranked 10,070th out of 14,666 executives tracked by ExecPay. In other words, Pietzke earned more than 31.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,070 out of 14,666 | 31st |
Division Manufacturing | 3,893 out of 5,772 | 33rd |
Major group Chemicals And Allied Products | 1,364 out of 2,075 | 34th |
Industry group Drugs | 1,105 out of 1,731 | 36th |
Industry Biological Products, Except Diagnostic Substances | 199 out of 313 | 36th |
Source: SEC filing on April 26, 2018.
Pietzke's colleagues
We found five more compensation records of executives who worked with Steffen Pietzke at PDL BioPharma in 2017.